Plain-English translation of NCT06946641 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing , a new oral medication taken as a capsule, to see how safe it is and how your body processes it. Researchers will study the medication in healthy volunteers first, then in people living with moderate to severe atopic dermatitis (a long-lasting skin condition that causes itching, redness, and inflammation). The goal is to understand whether this treatment could help reduce symptoms and improve quality of life.
Atopic dermatitis can be severely uncomfortable and resistant to current topical treatments (creams and ointments applied to the skin). This trial exists to explore whether an oral medication could provide a new option for people whose skin condition isn't adequately controlled with existing therapies.
You likely qualify if…
You likely don't qualify if…
Your participation depends on which part of the study you join. Healthy volunteers will either take a single dose of the medication and be monitored for side effects, or take daily doses for 14 days while researchers measure how your body handles the treatment. Some participants will test how food affects the medication by taking it with and without a large meal in separate visits. If you have atopic dermatitis, you will take the medication for multiple doses over time while researchers track your skin symptoms, itch relief, and any side effects through clinical visits and symptom tracking.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China